Evidence map›Paper›PMID 32722650›Full record

ReviewMolecules (Basel, Switzerland)2020

Synthesis of DNA Origami Scaffolds: Current and Emerging Strategies.

Joshua Bush, Shrishti Singh, Merlyn Vargas, Esra Oktay, Chih-Hsiang Hu, Remi Veneziano

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Immobilization of Enzyme Cascades with DNA Scaffolds.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. In Vivo Interactions of Nucleic Acid Nanostructures With Cells.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  11. Plugging synthetic DNA nanoparticles into the central dogma of life.Chemical communications (Cambridge, England) · 2024
    Review
  12. Article
  13. Advancements in Aptamer-Driven DNA Nanostructures for Precision Drug Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joshua BushVolgenau School of Engineering, Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0003-3231-5333
Shrishti SinghVolgenau School of Engineering, Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0001-5180-3936
Merlyn VargasVolgenau School of Engineering, Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-6234-711X
Esra OktayVolgenau School of Engineering, Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-8269-3546
Chih-Hsiang HuVolgenau School of Engineering, Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-6068-0728
Remi VenezianoVolgenau School of Engineering, Department of Bioengineering, George Mason University, Fairfax, VA 22030, USA.ORCID 0000-0002-2726-3770

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA origami nanocarriers have emerged as a promising tool for many biomedical applications, such as biosensing, targeted drug delivery, and cancer immunotherapy. These highly programmable nanoarchitectures are assembled into any shape or size with nanoscale precision by folding a single-stranded DNA scaffold with short complementary oligonucleotides. The standard scaffold strand used to fold DNA origami nanocarriers is usually the M13mp18 bacteriophage's circular single-stranded DNA genome with limited design flexibility in terms of the sequence and size of the final objects. However, with the recent progress in automated DNA origami design-allowing for increasing structural complexity-and the growing number of applications, the need for scalable methods to produce custom scaffolds has become crucial to overcome the limitations of traditional methods for scaffold production. Improved scaffold synthesis strategies will help to broaden the use of DNA origami for more biomedical applications. To this end, several techniques have been developed in recent years for the scalable synthesis of single stranded DNA scaffolds with custom lengths and sequences. This review focuses on these methods and the progress that has been made to address the challenges confronting custom scaffold production for large-scale DNA origami assembly.

Indexed as

NanotechnologyBacteriophage M13DNADNA, Single-StrandedNanostructuresNucleic Acid ConformationOligonucleotidesDNADNA, Single-StrandedOligonucleotidesDNA amplificationDNA nanotechnologyDNA origamiDNA scaffoldsDNA Synthesisnucleic acid nanoparticlessingle-stranded DNA

Identifiers

PMID32722650
PMCPMC7435391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.